EXECUTIVE COMMITTEEPROGRAM COMMITTEE

第七届亚洲肝炎与艾滋病学术会议

7TH ASIAN CONFERENCEON HEPATITIS&AIDS

BEIJING, CHINA • 9-10 JUNE 2018FROM BASIC SCIENCE TO CLINICAL PRACTICE

ACHA

Local Honorary Chair (2018)Hui Zhuang, MD

Peking University Health Science Centre, ChinaJidong Jia, MD, PhD

Beijing Friendship Hospital, Capital Medical University, ChinaJinlin Hou, MD

Nanfang Hospital, Southern Medical University, China

Lai Wei, MD

Peking University People’s Hospital, China

Zhongping Duan, MD, PhD

Beijing You’an Hospital, China

Taisheng Li, MD, PhD

Peking Union Medical College Hospital, China

Stephen Locarnini, MD, PhD

Victorian Infectious Diseases Reference Laboratory, AustraliaCharles Boucher, MD, PhD

Erasmus Medical Centre, the Netherlands

Wei He, MD, PhD

Ministry of Health & Peking Union Medical College, China

Yiming Shao, MD, PhD

China CDC, China

Hongzhou Lu, MD, PhD

Shanghai Public Health Clinical Center, Fudan University, China

Jie Li, MD, PhD

Peking University Health Science Center, China

Aikichi Iwamoto, MD, DMSci

Japan Agency for Medical Research and Development (AMED), Japan

Jürgen Rockstroh, MD

University of Bonn, Germany

Jonathan Schapiro, MD

Sheba Medical Center, Israel

Bonaventura Clotet, MD, PhD

Hospital Universitari “Germans Trias i Pujol”, Spain

Registration and information: www.virology-education.com

EXECUTIVE CHAIR (2018)Yuan Huang, MD

Beijing Tsinghua Changgung Hospital, China

LOCAL CHAIR (2018)Jiahong Dong, MD, PhD

Beijing Tsinghua Changgung Hospital, China

ORGANIZER CO-ORGANIZER

See You in Beijing!

ENDORSERS

MEETING OBJECTIVES• Education on the state-of-art treatment options for Hepatitis B,

C, HIV and HIV co-infections

• Presentation of the latest research data, especially in the Asian context

• Translation of knowledge into clinical practice

• Providing a platform for interaction and dialogue

• Stimulating discussion among different disciplines

• Building collaborations among local, regional and national communities

INTRODUCTIONOver the years, treating viral diseases has become more and more complex. Given the increase in therapeutic options in Asia, clinicians and researchers will clearly benefit from the opportunity to be informed and to discuss the newest data and their implications for clinical practice.

This meeting aims at bridging the gap between the knowledge that is shared among experts in the field and the knowledge of researchers and clinicians in daily practice. Furthermore, this meeting provides a much-needed platform for researchers and clinicians involved in daily clinical management of HBV, HCV and HIV-infected patients. We believe this meeting will create a good opportunity for regional clinicians, researchers and pharmaceutical companies to meet each other and share knowledge.

UNIQUE FEATURES• A program particularly focusing on the

context of Asia.

• A unique event for researchers and clinicians involved in the field of hepatology and HIV treatment.

• A great opportunity to exchange information with international and regional leading scientists in the area.

WHY SHOULD YOU ATTEND? After participating in this meeting, the participants will:

• Have a thorough knowledge of the most recent results in drug development (including most recent clinical trials results) for HBV, HCV, and HIV.

• Be able to integrate the latest scientific results into daily clinical care to improve the treatment quality of HBV, HCV and HIV infected individuals.

MISSED THE PREVIOUS EDITIONS?View the presentations and webcasts on:

www.InfectiousDiseasesOnline.com

第七届亚洲肝炎与艾滋病学术会议

7TH ASIAN CONFERENCEON HEPATITIS&AIDS

BEIJING, CHINA • 9-10 JUNE 2018FROM BASIC SCIENCE TO CLINICAL PRACTICE